Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tilde Dombernowsky"'
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background Knowledge of what the pharmaceutical industry emphasizes when assessing trial sites during site selection is sparse. A better understanding of this issue can improve the collaboration on clinical trials and increase knowledge of h
Externí odkaz:
https://doaj.org/article/fd3d43d665d94a568d237275ef92c98d
Publikováno v:
Dombernowsky, T, Haedersdal, M, Lassen, U & Thomsen, S F 2019, ' Criteria for site selection in industry-sponsored clinical trials : a survey among decision-makers in biopharmaceutical companies and clinical research organizations ', Trials, vol. 20, 708 . https://doi.org/10.1186/s13063-019-3790-9
Trials, Vol 20, Iss 1, Pp 1-12 (2019)
Trials
Trials, Vol 20, Iss 1, Pp 1-12 (2019)
Trials
Background Knowledge of what the pharmaceutical industry emphasizes when assessing trial sites during site selection is sparse. A better understanding of this issue can improve the collaboration on clinical trials and increase knowledge of how to att
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a6b40cdf147d83cff073896bbf6a72
https://curis.ku.dk/ws/files/234698427/OA_Criteria_for_site_selection_in_industry_sponsored.pdf
https://curis.ku.dk/ws/files/234698427/OA_Criteria_for_site_selection_in_industry_sponsored.pdf
Autor:
Lise Lotte Gluud, Srdan Novovic, Tilde Dombernowsky, Marlene Østermark Kristensen, Sisse Rysgaard
Publikováno v:
Pancreatology. 16:756-760
Background The incidence of respiratory failure and other respiratory complications in the early phase of acute pancreatitis (AP) is not well investigated. Objective To evaluate the incidence and risk factors of respiratory failure, and its impact on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c4ed960c3298e2d83c07ac2c5dfad2
https://doi.org/10.1016/j.pan.2016.06.664
https://doi.org/10.1016/j.pan.2016.06.664
Publikováno v:
Dombernowsky, T, Hædersdal, M, Lassen, U & Thomsen, S F 2017, ' Development in the number of clinical trial applications in Western Europe from 2007 to 2015 : retrospective study of data from national competent authorities ', B M J Open, vol. 7, no. 7, e015579 . https://doi.org/10.1136/bmjopen-2016-015579
BMJ Open
BMJ Open
OBJECTIVE: To investigate the development in the number of applications for authorisation of clinical trials of medicines (CTAs) submitted annually to national competent authorities in 10 Western European member states of the European Union from 2007
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274ea6816ed9566b40a22123a9c09dbf
https://curis.ku.dk/portal/da/publications/development-in-the-number-of-clinical-trial-applications-in-western-europe-from-2007-to-2015(802f3926-1763-4305-bda2-b0c8e3d00534).html
https://curis.ku.dk/portal/da/publications/development-in-the-number-of-clinical-trial-applications-in-western-europe-from-2007-to-2015(802f3926-1763-4305-bda2-b0c8e3d00534).html
Publikováno v:
Ugeskrift for laeger. 170(4)
Do patients with fibromyalgia (FM) have reduced muscular strength? We examined 22 articles and conclude from the results of these that FM patients have reduced muscular strength in their hands and quadriceps. The material also suggests generalised re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22ac80be2bceeace6374c8a93e34c2ff
https://pubmed.ncbi.nlm.nih.gov/18282450
https://pubmed.ncbi.nlm.nih.gov/18282450